STAT+: ‘Skinny labels’ on generic medicines saved Medicare $15 billion over a recent six-year period
STAT
APRIL 30, 2024
A controversial provision of a federal law designed to speed copycat drugs to market and foster competition saved Medicare Part D nearly $15 billion from 2015 to 2021 on just 15 medicines during that period, according to a new analysis. In short, this is a so-called carve-out.
Let's personalize your content